China Botanic Pharmaceutical Stock Forecast, Price & News

0.00 (0.00 %)
(As of 05/6/2021 02:08 PM ET)
Today's Range
50-Day Range
52-Week Range
Volume52,135 shs
Average Volume56,783 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CBPI News and Ratings via Email

Sign-up to receive the latest news and ratings for China Botanic Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Current SymbolOTCMKTS:CBPI
Phone86 451 5762 0378
Year FoundedN/A

Sales & Book Value

Annual SalesN/A





Next Earnings DateN/A
OptionableNot Optionable


No headlines for this company have been tracked by MarketBeat.com

About China Botanic Pharmaceutical

China Botanic Pharmaceutical Inc. researches, develops, manufactures, and distributes of botanical products, bio-pharmaceutical products, and traditional Chinese medicines in the People's Republic of China. It offers botanical anti-depression and nerve-regulation products, including Acanthopanax, a Siberian ginseng that regulates the nervous system, delays aging process, strengthens the body, and treats neurasthenia, insomnia, cerebrovascular and cardiovascular diseases, and fatigue; Tianma tablets and compound Yangjiao tablets, which are botanic drugs for treating headaches and regulate nerves; and compound Schisandra tablets, a botanic drug used to regulate central nervous system, generate body fluids and alleviate thirst, nourish the kidneys, and cure insomnia and palpitations, as well as to cure neurasthenia. The company's biopharmaceutical products consist of Ginseng and Venison Extract, which comprises nutrients that nourish the blood and kidneys, and restore body's energy; and Badger oil expels that treats water and fire burns, scalds, and skin pain. Its botanical antibiotics and traditional over the counter Chinese medicines include Banlangen antiviral and broad-spectrum antibiotic granules; compound Honeysuckle antiviral, antibacterial, and anti-inflammatory granules; Shengmai granules, which regulate blood flow, strengthen heart beat, and improve the immune system and blood quality; and Qing Re Jie Du Oral Liquid that treats flu, upper respiratory infections, and sore throats. The company distributes its products through a network of approximately 3,000 distributors and approximately 70 sales centers. The company was formerly known as Renhuang Pharmaceuticals, Inc. and changed its name to China Botanic Pharmaceutical Inc. in November 2010. China Botanic Pharmaceutical Inc. was founded in 1996 and is headquartered in Harbin, China.


Overall MarketRank

0.00 out of 5 stars

Medical Sector

1907th out of 2,043 stocks

Pharmaceutical Preparations Industry

752nd out of 771 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

China Botanic Pharmaceutical (OTCMKTS:CBPI) Frequently Asked Questions

What stocks does MarketBeat like better than China Botanic Pharmaceutical?

Wall Street analysts have given China Botanic Pharmaceutical a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but China Botanic Pharmaceutical wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are China Botanic Pharmaceutical's key executives?

China Botanic Pharmaceutical's management team includes the following people:
  • Mr. Weiqiu Dong, Chief Accounting Officer (Age 50, Pay $91.99k)
  • Mr. David Elliot Lazar, Pres, Sec., CFO, CEO & Chairman (Age 30)
  • Mr. Fanrong Meng, VP (Age 48)
  • Mr. Dianjun Pi, Exec. Mang. and Director (Age 65)

Who are some of China Botanic Pharmaceutical's key competitors?

What is China Botanic Pharmaceutical's stock symbol?

China Botanic Pharmaceutical trades on the OTCMKTS under the ticker symbol "CBPI."

How do I buy shares of China Botanic Pharmaceutical?

Shares of CBPI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is China Botanic Pharmaceutical's stock price today?

One share of CBPI stock can currently be purchased for approximately $0.08.

How many employees does China Botanic Pharmaceutical have?

China Botanic Pharmaceutical employs 666 workers across the globe.

What is China Botanic Pharmaceutical's official website?

The official website for China Botanic Pharmaceutical is www.renhuang.com.

Where are China Botanic Pharmaceutical's headquarters?

China Botanic Pharmaceutical is headquartered at LEVEL 11 CHANGJIANG INTL BLDG NO.28 CHANGJIANG ROAD NANGANG DISTRICT, HARBIN F4, 150090.

How can I contact China Botanic Pharmaceutical?

China Botanic Pharmaceutical's mailing address is LEVEL 11 CHANGJIANG INTL BLDG NO.28 CHANGJIANG ROAD NANGANG DISTRICT, HARBIN F4, 150090. The company can be reached via phone at 86 451 5762 0378 or via email at [email protected]

This page was last updated on 5/6/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.